Safe Harbor Financial Statement on Federal Cannabis Rescheduling and the Resulting Growth Opportunity for Its Banking Platform Improved operator economics and expanding institutional interest position Safe Harbor for scalable, compliant growth GlobeNewswire December 18, 2025 DENVER, Dec. 18, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (NASDAQ: SHFS) (“Safe Harbor” or the […]

Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors GlobeNewswire December 18, 2025 FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D., Ph.D., to the Company's Board of

HF Foods Group Opens State-of-the-Art Distribution Warehouse in Powder Springs, GA Opens an advanced 190,000 square foot distribution center driven by increased market demand GlobeNewswire December 18, 2025 POWDER SPRINGS, Ga., Dec. 18, 2025 (GLOBE NEWSWIRE) — HF Foods Group (Nasdaq: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to

Toronto, Ontario–(Newsfile Corp. – December 18, 2025) – Mines D’Or Orbec Inc. (TSXV: BLUE) (OTC Pink: BLTMF) (“Orbec” or the “Company“) is pleased to announce that the Ontario Superior Court of Justice (Commercial List) issued a final order approving the previously announced plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement“) pursuant to

(NASDAQ:CUE), BOSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced that it is commencing an underwritten public offering of shares of its common stock (or

Cue Biopharma Announces Proposed Public Offering GlobeNewswire December 18, 2025 BOSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced that it is commencing an underwritten

December 19, 2025 – Sydney, Australia https://mma.prnewswire.com/media/2849170/PMET_Resources_Inc__Share_issuance_to_VW_Group.jpg PMET Resources Inc. (the “Company” or “PMET”) (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to advise that its largest strategic investor, Volkswagen Finance Luxemburg S.A. (Volkswagen), has accepted an offer by the Company to subscribe for 89,125 fully paid common shares in the Company at

Double-Digit Earnings Growth Driven by Best-Selling Global Publishing Board Authorizes $150 Million Expanded Share Repurchase Authorization as Initial Step to Deploy Proceeds from Successful Sale-Leaseback Transactions Scholastic Corporation (NASDAQ: SCHL), the global children's publishing, education and media company, today reported financial results for the Company's fiscal second quarter ended November30, 2025. https://mma.prnewswire.com/media/344322/SCHOLASTIC_Logo_v1.jpg Peter Warwick, President

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or

(NASDAQ:BEAM), CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 5:15 p.m. PT in San